Tamara Lamb
Adult Health · University Park, FLNPI 1154446177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,022 and has fallen 97.4% since, to $27 in 2024.
Across 60 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$190
- AstraZeneca$83
- AbbVie$82
- Foundation Medicine, Inc.$78
- Johnson & Johnson$71
- Amgen$44
- plus $584 from 28 others
What the payments were for
- Food & beverage$1,03291%
- Education$1009%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 6 | $190 |
| AstraZeneca(2 entities) | 5 | $83 |
| AbbVie | 4 | $82 |
| Foundation Medicine, Inc. | 1 | $78 |
| Johnson & Johnson(2 entities) | 5 | $71 |
| Amgen | 2 | $44 |
| Pfizer | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Seagen Inc. | 2 | $33 |
| Myovant Sciences Inc. | 2 | $29 |
| Bayer | 2 | $27 |
| Taiho Oncology, Inc. | 2 | $26 |
| Boston Scientific | 2 | $26 |
| Jazz Pharmaceuticals Inc. | 2 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Gilead | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Novartis | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Array Biopharma Inc | 1 | $17 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Dova Pharmaceuticals | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
| Morphosys, US Inc. | 1 | $13 |
| Merck | 1 | $11 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
| Puma Biotechnology, Inc. | 1 | $11 |
How this compares
$1,132 in reported general payments places this provider in the 65th percentile of 2,237 adult health providers in Florida.
Other adult health in University Park
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.